Clorox (NYSE: CLX) reported Q2 EPS of $1.39, $0.05 worse than the analyst estimate of $1.44. Revenue for the quarter came in at $1.67 billion versus the consensus estimate of $1.64 billion.

GUIDANCE:

Clorox sees FY2026 EPS of $5.95-$6.30, versus the consensus of $5.95.

For earnings history and earnings-related data on Clorox (CLX) click here.